Skip to main content

Clinical Trials Using Fecal Microbiota Transplantation Capsule

Review the clinical trials studying fecal microbiota transplantation capsule on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-4 of 4

Restorative Microbiota Therapy in Combination with Durvalumab, Tremelimumab, and Chemotherapy for the Treatment of Stage IIIB-IV Non-small Cell Lung Cancer
Status: Active
Location: 2 locations
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Fecal Microbiota Transplantation for Reducing Gut-Related Side Effects and Improving Treatment Outcomes in Patients with B-Cell Lymphoma Receiving CAR T-cell Therapy
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington